Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alzheimer's Disease
|
1843 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.900 | 0.950 | 20 | 2009 | 2019 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 3 | 2012 | 2013 | |||||
Serum LDL cholesterol measurement
|
555 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 3 | 2012 | 2013 | |||||
Autoantibody measurement
|
52 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||
C-reactive protein measurement
|
624 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Serum total cholesterol measurement
|
1243 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Squamous cell carcinoma
|
257 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Triglycerides measurement
|
1418 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||
CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO
|
1 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.700 | 0 | ||||||||
Chronic Kidney Diseases
|
306 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.020 | 1.000 | 2 | 2009 | 2009 | |||||
Impaired cognition
|
348 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Age related macular degeneration
|
663 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Age-related cognitive decline
|
3 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Alzheimer Disease, Late Onset
|
243 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Arteriosclerosis
|
267 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Atherosclerosis
|
281 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Cerebral atrophy
|
44 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Cerebral cortical atrophy
|
13 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Cerebral Palsy
|
69 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Cerebral Vasospasm
|
3 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Decreased Attention
|
3 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Dementia
|
176 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1 | 2019 | 2019 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Leprosy, Multibacillary
|
16 | 0.667 | 0.480 | 19 | 44905579 | upstream gene variant | T/G | snv | 0.58 | 0.010 | 1.000 | 1 | 2018 | 2018 |